Basecamp Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Basecamp Wealth Advisors's AMGN Position: Q3 2026 in Review
Basecamp Wealth Advisors reduced its Amgen (AMGN) stake by 44% in Q3 2026, selling an estimated $510K and leaving 1,643 shares worth $693K. The position accounts for 0.16% of the portfolio, ranked #67.
Basecamp Wealth Advisors first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.06M in Q2 2026. 3,227 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Basecamp Wealth Advisors held 1,643 shares of Amgen worth $693K as of Q3 2026.
- Basecamp Wealth Advisors sold 1,279 Amgen shares in Q3 2026, an estimated $510K.
- Amgen made up 0.16% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #67 holding.
- Basecamp Wealth Advisors first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
- Basecamp Wealth Advisors's Amgen position peaked at $1.06M in Q2 2026.
- 3,227 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.